Global Oncology Precision Medicine Market is driven by the several benefits offered by Promise of Tailoring Cancer Care to Handle Individual Patient Characteristics.
Global Oncology Precision Medicine Market to Grow with 11.6% CAGR from 2022 to 2027
The Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients' tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient's cancer that best matches, or targets, the culprit mutations in the tumor DNA.
